The antibiotics Streptovirudin and 24010 were tested to determine their effects on the formation of lipid-Unked saccharide intermediates associated with glycoprotein biosynthesis in mung bean ( Vigna radiata) and suspension-cultured soybean cells (Glycine max cv. Mandarin). In vitro both compounds strongly inhibited the transfer of N-acetylj3Hlglucosamine from UDP-N-13Hlacetylglucosamine to N-acetylglucosaminyl-pyrophosphoryl-polyisoprenol and lipid-linked oligosaccharides, although they had no apparent effect on the incorporation of I14Clmannose from GDPI14Clmannose into mannosyl-phosphoryl-dolichol with a small inhibition into lipid-linked oligosaccharides. In vivo, Streptovirudin and tunicamycin dramatically inhibited the incorporation of N-1 4Clacetylglucosamine and 13Hlmannose into Pronase-released material (glycoproteins), whereas there was no effect on 13Hlleucine incorporation into Pronase-released material (protein). Because the action of Streptovirudin and antibiotic 24010 in plants and other systems is similar to that for tunicamycin, these antibiotics are believed to be closely related. The use of tunicamycin is discussed with respect to its importance in studying glycoprotein biosynthesis and function in animal and plant systems.
and it does not inhibit the transfer of the second GlcNAc from UDP-GIcNAc to GlcNAc2-P-P-Dol. Amphomycin inhibits the transfer of Man from GDP-Man to Man-P-Dol and to lipid-linked oligosaccharides. Bacitracin seems to inhibit every step mentioned above.
In this paper two new antibiotics are described, streptovirudin (2) and antibiotic 24010 (20) . Results suggest that these antibiotics are similar in action to tunicamycin. We also compare previously published in vitro effects of tunicamycin with in vivo results obtained using suspension-cultured soybean cells.
MATERIALS AND METHODS
Chemicals. UDP-[6-3H]GlcNAc (6.6 Ci/mmol), GDP-[U- (20 g/l), 2,4-D (2 mg/l), nicotinic acid (1 mg/l), pyridoxine (1 mg/l), thiamine-HCl (I mg/l), myo-inositol (300 mg/l), and casamino acids (400 mg/l).
The pH was adjusted to 6.0. Cells were grown at 27 C with continuous shaking. (29) . For both at concentrations as high as 12.5 ,ug/ml, inhibition was essentially the same. We expected the transfer of Man (from GDPMan and Man-P-Dol) into lipid-linked oligosaccharides to be inhibited, since these antibiotics inhibit GlcNAc incorporation (from UDP-GlcNAc) into GlcNAc-P-P-Dol and should substantially reduce the level of N,N'-diacetylchitobiosyl-lipid, a necessary acceptor for the Man Thus, streptovirudin appears to inhibit glycosylation of protein specifically rather than protein synthesis itself.
The in vivo effects of tunicamycin were similar to those seen with streptovirudin, except that on a weight basis tunicamycin was ['4CJGlcNAc into glycoprotein about 75 and 65%, respectively; with 5 i.g/ml of tunicamycin, glycoprotein synthesis was almost completely blocked (90 and 85%, respectively). GlcNAc incorporation into glycoprotein appears to be more sensitive to tunicamycin than Man incorporation. At a concentration of 5 jig/ml of tunicamycin the rate of Man incorporation into glycoprotein was about 10 times higher than the rate of incorporation for GlcNAc (Fig. 8) . Thus, tunicamycin appears to be a potent inhibitor of glycosylation in in vivo as well as in vitro plant and animal systems.
Tunicamycin also decreased incorporation of ['4C]GlcNAc into pellet fractions by about 55% (at 5 ,ug/ml antibiotic), whereas hardly any inhibition was noted for [3H]Man. DISCUSSION The action of streptovirudin and antibiotic 24010 on the biosynthesis of lipid-linked saccharides is similar to tunicamycin as demonstrated by this study using particulate mung bean fractions and whole soybean cells, and for studies using pig aorta microsomal fractions (4) . The prime factor in vitro is that these antibiotics effectively inhibit the transfer of GlcNAc from UDP-A. 24 h, all activity of each was abolished (4) . We concluded that each antibiotic very likely contains a sugar residue (probably glucosamine as has been determined for tunicamycin). Furthermore, tunicamycin and streptovirudin are said to have similar chromatographic properties (2).
Tunicamycin has been very useful in systems where glycoproteins are involved. Because tunicamycin prevents glycosylation of glycoproteins, it has been used to study the role of glycosylation in secretion and turnover. For example, glycosylation appears to be required for immunoglobulins to be secreted by mouse and rat plasma cells (13) and for invertase and acid phosphatase to be released to the medium by yeast (17) . Other authors report that glycosylation is not essential for the secretion of fibronectin by chick fibroblasts (22) or very low density lipoprotein and transferrin by hepatocytes (27) . For chick fibronectin, however, in the absence of the carbohydrate moiety, proteolytic degradation increased substantially, indicating that glycosylation may help stabilize proteins against turnover. In viral systems where a glycoprotein coat is synthesized, tunicamycin effectively inhibits glycosylation and replication (19, 25) .
Where glycoproteins are involved in cell-cell recognition and binding, tunicamycin can be useful in studying the events and requirements for these processes. When canine kidney cells are infected with influenza virus, the cells readily bind group B streptococci (24) . If tunicamycin is added at the time of virus infection of the kidney cells, the bacteria will not bind to the kidney cells (23) . This evidence supports the notion that the virus makes a glycoprotein that is inserted into the mammalian cell membrane that confers streptococcus-binding capabilities to the kidney cells. The potential use of the tunicamycin group of antibiotics in cell recognition has yet to be realized in plants. With the aid of tunicamycin we are currently investigating the possible role of glycoproteins in the specific binding of Rhizobium japonicum to soybean cells in culture (14) .
